Vimarsana
Biggest News Aggregation in the World

Ale Kremlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ale Kremlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ale Kremlin Today - Breaking & Trending Today

Sjogren's Without Dryness? Yes, It's a Thing - Vimarsana News

Sjogren's Without Dryness? Yes, It's a Thing

New study delves into unusual presentation

ENDO 2023 Roundup: More Imcivree Data; Statement on Aging; Novel Hypoparathyroid Tx - Vimarsana News

ENDO 2023 Roundup: More Imcivree Data; Statement on Aging; Novel Hypoparathyroid Tx

Some more highlights from the Endocrine Society's annual meeting

Mirum Pharmaceuticals to Showcase LIVMARLI Data at ESPGHAN Annual Meeting - Vimarsana News

Mirum Pharmaceuticals to Showcase LIVMARLI Data at ESPGHAN Annual Meeting

Seven abstracts accepted including four oral presentations Phase 3 MARCH PFIC data selected as one of highest scoring abstracts and will be presented during the plenary session on May 18 RISE... | May 17, 2023

What is a 'protected tenant' in France and how do you become one? - Vimarsana News

What is a 'protected tenant' in France and how do you become one?

We explain requirements for this special status

Mirum Pharmaceuticals' LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and Older - Vimarsana News

Mirum Pharmaceuticals' LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and Older

Mirum Pharmaceuticals’ LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and OlderDec 13, 2022- First and only medication approved in both the U.S. and Europe to treat cholestatic pruritus in patients with Alagille...